The $31,000 Salary
In 2018, Rick Smith agreed to be paid $24 per hour. Not approximately, not metaphorically — the co-founder and CEO of what was then a $2.5 billion public company accepted an annual base salary of roughly $31,000, waiving all bonuses, all other incentive compensation, and all the conventional mechanisms by which public-company CEOs extract wealth from the organizations they lead. In exchange, he received a package of stock options that would vest in twelve tranches, each unlocked only when Axon's market capitalization climbed another billion dollars above its starting point, and only when the company simultaneously hit escalating revenue or adjusted-EBITDA targets. If Axon's stock went sideways — or if it rose on multiple expansion alone, without the operational performance to match — Smith would earn essentially nothing for a decade's work. His wife told him it was too risky. He took the deal anyway.
Five years later, he had cleared all twelve tranches. The stock had appreciated more than 600%. Smith became the highest-paid CEO in America in 2023, with compensation valued at $165 million. Then he negotiated his next performance plan — a new set of targets designed to keep him at the company through at least 2030, with a goal of driving the stock to $943.75 per share — and took $88 million of the potential payout and redirected it to the lowest-paid employees at Axon, granted in surprise equity awards calibrated to years of service. The man who'd started out building stun guns in a garage in the mid-1990s had, through a combination of missionary zeal and compounding strategic bets, assembled something far stranger and more durable than a weapons company: a vertically integrated operating system for public safety, wired together by cloud software and recurring revenue, with the Taser serving as the original Trojan horse.
That the same device synonymous with controversial police use-of-force incidents would become the wedge product for one of the most successful SaaS transformations in American business is the paradox at the center of Axon's story. The company builds instruments of state violence — and it also builds the cameras, the storage infrastructure, the AI-powered report-writing tools, and the digital evidence management systems designed to hold that violence accountable. It profits from the proliferation of surveillance technology — and it established an independent AI ethics board that recommended against adding facial recognition to its body cameras. It sells to every major police department in America — and its stated corporate mission is to "obsolete the bullet."
The contradictions are not incidental to the business. They are the business.
By the Numbers
The Axon Machine
$2.1BFY2024 revenue
~$46BMarket capitalization (early 2025)
$850M+Annual recurring revenue (Q2 2024 run rate)
122%Net revenue retention rate (Q2 2024)
600,000+Law-enforcement officers carrying Taser devices worldwide
200,000+Axon Body 4 cameras deployed
$52BTotal addressable market (company estimate, 2021)
10Consecutive quarters of 25%+ YoY revenue growth (as of Q2 2024)
Garage Ballistics
The founding mythology is, like most founding mythologies, both true and carefully edited. In 1993, Rick Smith was a twenty-three-year-old with an MBA from the University of Chicago and a recently abandoned career at a management consultancy. Two of his high school classmates had been killed in road-rage shootings in the Phoenix metro area. Smith — techno-optimist, systems thinker, a man who would later compare the societal transition away from firearms to the transition from horses to automobiles — became fixated on a question: could you build a weapon effective enough to incapacitate a person but designed, from first principles, to avoid killing them?
He found his answer in a nearly forgotten government research program. In the early 1970s, a NASA researcher named Jack Cover had developed a device that fired two small barbed darts connected to the gun by thin wires, delivering a pulsed electrical current that caused involuntary muscle contraction — neuromuscular incapacitation, in the clinical parlance. Cover named it the Thomas A. Swift Electric Rifle, after the boy-inventor adventure novels he'd loved as a child, acronymized it as TASER, and spent two decades failing to commercialize it. The original device used gunpowder charges to propel its darts, which classified it as a firearm under federal law — a regulatory categorization that hobbled its market potential.
Smith, along with his brother Tom, partnered with the aging Cover and redesigned the propulsion system to use compressed nitrogen instead of gunpowder, sidestepping the firearms classification. They incorporated TASER International in Scottsdale, Arizona, in 1993. The first years were hand-to-mouth. The Smiths built prototypes in their garage, demoed the device at police conferences, and burned through personal savings. Law enforcement was skeptical. The brothers were, in essence, asking cops to trust their lives to a weapon made by two guys with no background in weapons systems, no defense-industry credentials, and a product that, if it failed at the critical moment, could get an officer killed.
What changed the trajectory was a product redesign — and a shift in customer psychology. In 1999, TASER introduced the M26, a device shaped like a handgun and powerful enough to drop a large, combative suspect in seconds. The ergonomic familiarity was deliberate: the company understood that officers needed to reach for the Taser with the same trained muscle memory they used for their sidearms. The M26 worked. Departments began buying. By 2001, more than a hundred police agencies had adopted the device. By 2004, the number had passed seven thousand.
Smith had found his wedge.
The Lethality Paradox
The same year TASER's adoption was accelerating through American police departments, the controversy that would shadow the company for two decades was also accelerating. Between 2001 and 2018, according to a Reuters investigation, more than a thousand people died in the United States in incidents involving Taser deployments — not necessarily caused by the device, but within what the news agency called "a larger mosaic of force." Civil-liberties organizations argued that officers, rather than using the Taser strictly as an alternative to deadly force — its marketed purpose — were deploying it as a compliance tool in situations that would never have warranted a firearm. A 2016 ruling from the Fourth Circuit Court of Appeals, following the death of a mentally ill man in North Carolina who was Tased five times in two minutes, declared that such use constituted "unconstitutionally excessive" force.
The company's response was characteristic of Smith's worldview: the problem was real, but the solution was more technology, not less. If officers were misusing the device, the answer was better data, better training, and — crucially — better recording. "Solutions that create problems in need of solutions: that, he told me, is the definition of business," Smith explained to The New Yorker in 2018. The sentence reveals something essential about the man. He is not cynical. He genuinely believes that the feedback loop between technology deployment and technology refinement is the primary mechanism of civilizational progress. He is also, plainly, aware that this feedback loop generates extraordinary commercial opportunity.
Today, would you keep a sword by your bed? No! It's ridiculous. But firing hot projectiles of lead shrapnel at people — we want to make that a ridiculous concept, because it's a brutal, outdated, terrible thing to do.
The lethality controversy shaped Axon's strategy more profoundly than any market analysis or competitive threat. It forced the company — or perhaps gave Smith the justification — to build the infrastructure of accountability alongside the infrastructure of force. In 2006, TASER began integrating cameras into its weapons, initially as a defensive measure: if every deployment was recorded, the company reasoned, false allegations of abuse could be rebutted and legitimate misuse could be identified and corrected. The camera attachment was, at first, a modest product extension. It would become, over the following decade, the fulcrum on which the entire business model pivoted.
The iPod/iTunes Insight
Smith has used the iPod/iTunes analogy so often it has become an article of faith within the company, repeated in investor presentations, earnings calls, and press interviews with the fluency of a catechism. The idea is simple enough: Apple's music player was valuable, but the recurring ecosystem around it — the iTunes Store, the content library, the lock-in created by format and convenience — was where the durable economics lived. The hardware was the hook. The software was the line.
For Axon, the Taser was the iPod. But the body camera was the device that actually opened the iTunes door.
In the mid-2010s, the Black Lives Matter movement and a series of high-profile police shootings thrust body-worn cameras into the center of American policing debates. Departments that had resisted the technology for years suddenly faced political pressure — from city councils, from citizen oversight boards, from the federal government itself — to equip officers with recording devices. Axon, which had been building camera technology since 2006, was positioned to capture the wave. By 2018, the company held contracts with more than half the major police departments in the United States.
But the cameras were never the real play. The real play was what happened to the video after it was recorded.
A single body camera, worn by a single officer for a single shift, generates gigabytes of footage. Multiply that by hundreds of thousands of officers, across tens of thousands of departments, across years of retention requirements mandated by courts and regulations, and the data-storage problem becomes immense. Axon's answer was Evidence.com — launched in 2009, initially as a straightforward cloud-hosting service for body-camera footage, and gradually expanded into a comprehensive digital evidence management platform capable of ingesting video from body cameras, in-car cameras, drones, interview rooms, and CCTV systems, as well as photographs, audio files, and documents.
Evidence.com was the inflection point. It transformed Axon from a hardware manufacturer — subject to the cyclicality, commoditization risk, and gross-margin compression that plague every hardware business — into a platform company with a software subscription at its center. The cameras had little intrinsic margin. The monthly storage and software fees, billed per officer, compounded.
Our focus on building best-in-class subscription software, with a positive user experience, has driven our annual recurring revenue to $327 million, tripling over three years.
The genius of the architecture was the bundling. In 2017, Axon introduced the Officer Safety Plan — a subscription package that combined Taser devices, body cameras, Evidence.com licenses, and other software tools into a single per-officer, per-month contract. The OSP was an inspired commercial mechanism: it lowered the upfront capital expenditure for cash-strapped police departments (spreading hardware costs over multi-year terms), dramatically increased Axon's revenue visibility (converting lumpy hardware sales into predictable recurring streams), and created switching costs that bordered on structural. Once a department's entire evidence chain — from capture to storage to court presentation — ran through Axon's ecosystem, migrating to a competitor meant not just replacing hardware but rebuilding an entire digital workflow.
By Q2 2024, more than 20% of the potential users within Axon's domestic state and local government base — estimated at approximately 711,000 sworn officers — were on an OSP offering. Annual recurring revenue had reached $850 million, growing 44% year over year. Net revenue retention was 122%, meaning existing customers were spending 22% more each year even before accounting for new department wins. The flywheel was spinning.
The Rename
In 2017, TASER International became Axon Enterprise, Inc. The name change was more than cosmetic. It was a declaration of strategic identity — a signal to investors, customers, and employees that the company's center of gravity had shifted from a single, controversial product to the networked ecosystem surrounding it. The term "axon" refers to the long projection of a nerve cell that conducts electrical impulses — an apt metaphor for a company building a network of connected devices transmitting data through a central nervous system of cloud software.
The rename also served a practical purpose. The Taser brand carried baggage. Every lawsuit, every death-in-custody headline, every Last Week Tonight segment landed on a company whose name was the product at the center of the controversy. By elevating "Axon" — the name that had been given to the body-camera line — to the corporate level, Smith created a degree of brand separation. The Taser remained a product. Axon was the platform.
Not everyone was convinced. Skeptics saw the rename as an attempt to paper over reputational risk with Silicon Valley branding. But the market ratified the strategy. Between the rename in 2017 and the end of 2023, Axon's market capitalization grew from approximately $2.5 billion to north of $25 billion. The Taser controversy didn't disappear, but it became one element within a much larger story — a story about cloud software, artificial intelligence, and the digitization of the entire criminal justice workflow.
The Software Soulmate
In September 2019, Axon hired Jeff Kunins from Amazon, where he had been vice president of Alexa Entertainment. Smith, with the mix of self-deprecation and ambition that characterizes his public persona, called Kunins "my software soulmate." The hire was a statement of intent. Smith had built the weapons company, had overseen the pivot to cameras, had orchestrated the Evidence.com platform. But he recognized, with rare candor for a founder-CEO, that his personal expertise didn't extend to the kind of enterprise-grade software development that the next phase of Axon's strategy required.
Kunins' onboarding included midnight ride-alongs with police officers and hours spent inside 911 dispatch centers. This wasn't corporate tourism. Axon's software roadmap was predicated on an intimate understanding of law-enforcement workflows — the friction points, the paperwork burden, the information bottlenecks that consumed officer time and delayed justice. The company had already developed AI applications that automatically populated police reports by capturing driver's license information from body-camera footage and software that blurred civilian faces on dash-cam video in real time. These were clever features. But the ambition was larger: to automate and connect every digital process in the chain from incident to adjudication.
In December 2021, Axon launched Attorney Premier, formally entering the justice software market. The product enabled prosecutors and defense attorneys to manage digital evidence — body-worn and in-car video, drone footage, interview-room recordings, photographs, audio, documents — within a single platform. The proliferation of digital evidence had created an acute bottleneck in the justice system: highly trained attorneys were spending hours manually managing files rather than preparing cases. Attorney Premier addressed the bottleneck. Axon estimated the justice software market at $1 billion.
The pattern was consistent. Axon identified a workflow adjacent to its existing ecosystem, built or acquired a tool to address it, and then integrated that tool into its subscription bundles. Each new module increased the switching costs for existing customers and expanded the per-officer revenue opportunity.
⚡
From Garage to Operating System
Key milestones in Axon's strategic evolution
1993TASER International incorporated in Scottsdale, Arizona. Rick and Tom Smith partner with inventor Jack Cover.
1999Launch of the M26, the first Taser shaped like a handgun. Police adoption accelerates.
2001IPO on the Nasdaq. Seven thousand police agencies using Taser devices.
2006First cameras integrated into Taser weapons, creating the body-camera product line.
2009Launch of Evidence.com, cloud-based digital evidence management.
2017Company renamed from TASER International to Axon Enterprise. Officer Safety Plan (OSP) bundles introduced.
2018Rick Smith accepts moonshot compensation plan with $31,000 base salary. Market cap: ~$2.5B.
The Ethics Board and the Surveillance Dilemma
In 2018, as public anxiety about AI, facial recognition, and mass surveillance reached a crescendo, Smith did something unusual for the CEO of a company that sells surveillance tools to the state: he created an independent advisory board designed to constrain his own product roadmap. The AI Ethics Board comprised ethicists, AI researchers, public-policy specialists, and law-enforcement representatives, and its mandate was to provide binding recommendations to Axon's management on the deployment of emerging technologies.
The board's most consequential early decision came in 2019, when it recommended that Axon not add facial recognition capabilities to its body cameras. The commercial logic for facial recognition was obvious — the technology would have made Axon's cameras dramatically more useful to police departments, and competitors were racing to offer it. But the ethics board concluded that the technology was insufficiently accurate, particularly for people of color, and that its deployment on body cameras — devices designed to be worn continuously, in public spaces, capturing the faces of anyone within range — posed unacceptable risks to civil liberties.
Axon's management followed the recommendation. In 2020, the board provided guidelines on automated license plate recognition, and management followed those as well. The decisions cost Axon revenue in the short term. They also bought the company something harder to quantify but arguably more durable: a degree of legitimacy in debates where the default posture of technology companies is maximalist data collection.
This is the tension at the core of Axon's positioning. The company is building "the world's largest and most trusted network of safety devices," as its own shareholder letters describe it — a network that connects weapons, cameras, drones, and potentially robots through a software platform that ingests, stores, and analyzes vast quantities of surveillance data. The word "trusted" is doing enormous work in that sentence.
Trust, for Axon, is not a brand attribute. It is a competitive moat. Police departments, city councils, and citizen oversight boards are more likely to award contracts to a company that can point to a credible, independent ethics governance structure than to one that cannot. The ethics board is, simultaneously, a genuine expression of institutional responsibility and a brilliant commercial strategy.
Whether those two things can remain aligned indefinitely is one of the defining questions of Axon's next decade.
The TASER 10 and the Hardware Renaissance
For a company that has been aggressively repositioning itself as a software platform, Axon has continued to invest with remarkable intensity in the product that started it all. The TASER 10, launched in 2023, represents the most significant redesign of the weapon in two decades. It fires ten probes rather than two — a change that addresses one of the Taser's persistent tactical limitations: if one of the two darts missed or failed to make proper contact, the weapon was essentially useless until reloaded. With ten independently targeted probes, the probability of effective incapacitation on the first trigger pull increases dramatically.
The TASER 10 is also, not incidentally, significantly more expensive than its predecessors, and its multi-probe design means higher consumable revenue over the life of the device. By Q2 2024, more than 100,000 TASER 10 units were in the field, and the company reported that its top four TASER 10 deals had come from newer customer verticals — international, U.S. federal, corrections, and enterprise — rather than from the domestic state-and-local base that had traditionally been the Taser's primary market.
This is worth pausing on. The TASER 10 is not merely a product refresh. It is a wedge into new markets — correctional facilities, federal agencies, international law enforcement, and increasingly, private-sector enterprise customers (think campus security, hospital security, corporate campuses). Each of these verticals represents a customer base that, once equipped with Taser hardware, becomes a candidate for the full Axon ecosystem: cameras, Evidence.com, productivity software, AI tools.
The hardware-to-software flywheel spins in both directions. New Taser customers become software prospects. New software capabilities make the hardware more valuable. And the Officer Safety Plan bundles ensure that every transaction — hardware or software — reinforces the contractual stickiness of the relationship.
The AI Bet
The most recent layer of Axon's strategy — and the one that is generating the most speculative enthusiasm among investors — is artificial intelligence. The company has been embedding AI capabilities into its products with increasing aggression since the late 2010s, but the generative-AI wave of 2023–2024 accelerated the roadmap dramatically.
The applications are specific and grounded in the workflow realities that Kunins' team identified through its embedded-with-cops approach to product development. Draft One, an AI tool launched in 2024, uses body-camera footage and audio to generate a first draft of a police report — a task that traditionally consumes hours of an officer's shift and represents one of the most hated aspects of the job. The tool doesn't replace the officer's judgment (the draft requires human review and approval), but it compresses the administrative burden from hours to minutes. For departments struggling with chronic staffing shortages, this is not a nice-to-have feature. It is a force multiplier.
Other AI applications include real-time transcription of officer interactions, automated redaction of civilian faces and license plates in video footage (critical for compliance with privacy regulations and public-records requests), and intelligent search across the vast archives of digital evidence stored in Evidence.com. The company has positioned these capabilities as a new product tier — the AI Era Plan — layered on top of existing subscriptions at additional per-officer-per-month pricing.
The AI layer has a second-order effect that may prove even more important than the direct revenue it generates: it deepens the data moat. Every department that uses Draft One is feeding officer reports, body-camera footage, and incident data through Axon's AI models. The models improve with scale. The improvements make the product stickier. The stickier the product, the more data flows through it. It is the classic data-network-effect loop, applied to a market — public safety — where the barriers to entry are already formidable and the consequences of model failure (a wrongly generated report, a misidentified suspect) create an enormous quality premium.
We're in amazing position to take advantage of the AI era.
The International Frontier and the Enterprise Pivot
For most of its history, Axon has been an overwhelmingly domestic business, selling primarily to U.S. state and local law-enforcement agencies. That concentration has been both a strength — deep relationships, intimate understanding of the customer, regulatory familiarity — and a vulnerability. The U.S. state-and-local market is large but finite: approximately 711,000 sworn officers in the domestic base, by the company's own estimate. At some point, penetration plateaus.
The growth vectors that Axon has been pursuing with the most urgency are international expansion and enterprise verticals. International revenue grew 49% year over year in Q2 2024, outpacing the company's already blistering overall growth rate. The enterprise customer base — hospitals, universities, private security, transportation hubs — represents an entirely new category of buyer, one that values the same combination of less-lethal weapons, cameras, and digital evidence management but operates under different regulatory frameworks and procurement cycles.
Each new vertical extends the TAM. In November 2021, Axon laid out a $52 billion total addressable market estimate at its Investor Day — a number that struck many analysts as aspirational but that reflected the company's view of itself not as a weapons manufacturer, not even as a body-camera company, but as the technology infrastructure layer for the global safety market. Whether that number is realistic or promotional is, in a sense, beside the point. What matters is that the product architecture — the OSP bundles, the Evidence.com platform, the AI tools, the layered subscription model — is designed to capture revenue from adjacent categories without requiring fundamental retooling.
Rule of 40 with Hardware
Axon measures itself against the Rule of 40 — the SaaS benchmark stipulating that a company's revenue growth rate plus its profit margin should exceed 40%. This is an audacious framing for a business that still generates a substantial portion of its revenue from physical hardware, with the inherent gross-margin and inventory-management challenges that entails. But it reveals how Axon wants to be valued: not as a defense contractor, not as a consumer-electronics company, but as a software-platform business that happens to distribute its software through hardware devices.
The numbers support the framing more than skeptics might expect. In FY2021, Axon delivered 27% revenue growth and 20.6% adjusted-EBITDA margins — a combined 47.6%, well above the Rule of 40 threshold. By Q2 2024, with revenue growing 35% and adjusted-EBITDA margins at 24.5%, the math was even more favorable. The company's long-term financial targets, reiterated across multiple shareholder letters, call for 20%+ annual revenue growth with underlying adjusted-EBITDA margins of 30% — a Rule of 50+ aspiration.
The strategic logic of the Rule of 40 framing is that it justifies reinvestment at the expense of near-term profitability. Axon has been deliberately running its EBITDA margins below their potential ceiling, plowing the delta into R&D (AI capabilities, new hardware platforms, international infrastructure) and sales capacity. The argument to shareholders is: we could be a 30%-margin business today; we're choosing to be a 24%-margin business because the reinvestment is generating 35%+ top-line growth. As long as the growth persists, the market rewards the tradeoff.
The Founder's Wager
Smith laid out his personal philosophy of technology and violence in his 2019 book,
The End of Killing: How Our Newest Technologies Can Solve Humanity's Most Ancient Problem. The book is part manifesto, part corporate origin story, and part speculative forecast about a future in which advances in less-lethal weapons, surveillance, and artificial intelligence converge to make lethal force genuinely unnecessary. It is earnest in a way that makes cynics uncomfortable and optimistic in a way that makes ethicists uneasy.
The book illuminates the intellectual framework behind Axon's strategic choices. Smith does not see the Taser, the body camera, the evidence platform, and the AI layer as separate products. He sees them as components of a single system designed to shift the equilibrium of state violence from lethal to non-lethal, from opaque to transparent, from analog to digital. Whether this vision is genuine or retroactive rationalization for a series of commercially motivated product extensions is, perhaps, unknowable. What is knowable is that the vision has created a strategic architecture — the vertically integrated ecosystem, the bundled subscriptions, the data-network effects — that is extraordinarily difficult to replicate.
Consider the competitive landscape. No single rival competes across all of Axon's product categories. Motorola Solutions dominates in radio communications and command-center software but lacks a less-lethal weapons franchise. Flock Safety has built a strong position in automated license-plate recognition but doesn't manufacture hardware worn on an officer's body. Legacy justice-software vendors like Tyler Technologies operate in the court and records-management layer but lack the device ecosystem. To replicate Axon's full stack, a competitor would need to build or acquire a weapons business, a camera business, a cloud-evidence platform, an AI engine, and the trust relationships required to sell all of it to the same risk-averse, procurement-heavy customer base.
That is a moat.
How wide it is — and whether the AI era will deepen it or erode it — is the question the market is pricing at north of $40 billion.
In full candor, my wife was against me taking on the challenge, as she saw it as just too risky.
On a February morning in 2025, Axon reported its full-year 2024 results. Revenue had surpassed $2 billion for the first time. The Officer Safety Plan was deepening its penetration. The TASER 10 was ramping. The AI Era Plan was launching. The shareholder letter, signed by Brittany Bagley, the company's COO and CFO — a Harvard MBA who had arrived from General Electric and overseen the financial architecture of Axon's software transformation — carried the characteristic mix of mission-driven language and hard metrics. Somewhere in Scottsdale, a man who'd once been paid $31,000 a year to bet his career on a stun-gun company was already working on what he'd called, years earlier, the question that defined his business: "Where do you go next, what's Act II?" The Act II was already generating $850 million a year in recurring revenue. The question now was Act III. And on the wall of Axon's headquarters, in the hallway where visiting police chiefs and defense attorneys and enterprise security directors walked, the company's stated mission — Protect Life — remained two words that managed to sound both impossibly idealistic and, at the current stock price, enormously profitable.
